Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter

Retina

Volumn 31, Issue 8, 2011, Pages 1620-1626

  Lai, Yuhua ^a   Grattan, Joanne ^b   Shi, Yanyun ^c   Young, Graham ^a   Muldrew, Alyson ^a   Chakravarthy, Usha ^a,b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c SHANXI EYE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CAROTENOID;

ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTRAST SENSITIVITY; CONTROLLED STUDY; EARLY DIAGNOSIS; EYE FUNDUS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL TOMOGRAPHY; PERIMETRY; PREFERENTIAL HYPERACUITY PERIMETRY; RAMAN SPECTROMETRY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; RETINA NEOVASCULARIZATION; VASCULAR LESION; VISUAL ACUITY; VISUAL STIMULATION;

ANTIOXIDANTS; ASCORBIC ACID; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; FALSE NEGATIVE REACTIONS; HUMANS; LUTEIN; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELD TESTS; VITAMIN E; WET MACULAR DEGENERATION; XANTHOPHYLLS; ZINC;

EID: 80052449729     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31820d3ed1     Document Type: Article

References (12)

1. Maguire MG, Alexander J, Fine SL. Characteristics of choroidal neovascularisation in the complications of agerelated macular degeneration prevention trial. Ophthalmology 2008;115:1468-1473.
2. Lowenstein A. The significance of early detection of agerelated macular degeneration. Richard and Hinda Rosenthal Foundation Lecture. Retina 2007;27:873-878.
3. PHP Research Group. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina 2005;25:296-303.
4. PHP Research Group. Preferential hyperacuity perimeter (PreView PHP) for detecting choroidal neovascularisation Study. Ophthalmology 2005;112:1758-1765.
5. Trevino R, Kynn MG. Macular function surveillance revisited. Optometry 2008;79:397-403.
6. Neelam K, Hogg R, Stevenson MR, et al. Carotenoids and coantioxidants in age-related maculopathy. Design and methods. Ophthalmic Epidemiol 2008;15:389-401.
7. Klein R, Davis MD, Magli YL. The Wisconsin age-related maculopathy grading system.Ophthalmology 1991;98:1128-1134.
8. Isaac DL, Avila MP, Cialdini AP. Comparison of the original Amsler grid with the preferential hyperacuity perimeter for detecting choroidal neovascularisation in age-related macular degeneration. Arg Bras Oftalmol, 2007;70:771-776.
9. Kampmeier J, Zorn MM, Lang GK, Botros YT, Lang GE. Comparison of the preferential hyperacuity perimeter (PHP) test and Amsler grid test in the diagnosis of different stages of age-related macular degeneration. Klin Monatsbl Augenheilkd 2006;223:752-756. (Pubitemid 44681429)
10. Klatt C, Sendtner P, Ponomareva L, et al. Diagnostics of metamorphopsia in retinal diseases of different origins. Ophthalmology 2006;103:945-952. (Pubitemid 44769919)
11. Brown DM, Kaiser PK,Michels M, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444. (Pubitemid 44511558)
12. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431. (Pubitemid 44511557)